Oxford Biomedica plc (OTCMKTS:OXBDF) Short Interest Update

Oxford Biomedica plc (OTCMKTS:OXBDFGet Free Report) was the recipient of a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 800 shares, a growth of 300.0% from the November 30th total of 200 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is presently 8.0 days.

Oxford Biomedica Stock Performance

Shares of OTCMKTS OXBDF remained flat at $5.35 during midday trading on Thursday. The company has a debt-to-equity ratio of 1.48, a quick ratio of 2.07 and a current ratio of 2.35. Oxford Biomedica has a 1 year low of $2.09 and a 1 year high of $5.68. The firm has a 50-day simple moving average of $5.30 and a two-hundred day simple moving average of $4.74.

About Oxford Biomedica

(Get Free Report)

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.

See Also

Receive News & Ratings for Oxford Biomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biomedica and related companies with MarketBeat.com's FREE daily email newsletter.